Edition:
Deutschland

Sumitomo Dainippon Pharma Co Ltd (4506.T)

4506.T on Tokyo Stock Exchange

1,366JPY
03:10 Uhr
Change (% chg)

¥53 (+4.04%)
Prev Close
¥1,313
Open
¥1,315
Day's High
¥1,372
Day's Low
¥1,315
Volume
254,500
Avg. Vol
993,844
52-wk High
¥2,219
52-wk Low
¥1,166

Sumitomo Dainippon Pharma Co., Ltd., is a pharmaceutical company. The Company operates in four segments. The Japan segment manufactures and sells medical drugs. The North America segment manufactures, develops, purchases and sells ethical drugs. The China segment manufactures and sells ethical drugs through its consolidated subsidiary. The Other Overseas division is involved in the development of its products in Europe. The Company is also engaged in the manufacture, purchase, sale and supply of food materials and additives, chemical products, veterinary drugs, diagnostic products and inspection services of clinical pathology for animal, the manufacture of extracts, as well as the storage, delivery and clinical inspection of drugs.

Company Address

Sumitomo Dainippon Pharma Co Ltd

2-6-8, Dosho-machi, Chuo-ku
OSAKA-SHI   OSK   541-0045
P: +816.62035321
F: +816.62026028

Company Web Links

Officers & Directors

Name Age Since Current Position

Masayo Tada

75 2018 Chairman of the Board, Representative Director

Hiroshi Nomura

62 2018 President, Representative Director

Hitoshi Odagiri

63 2019 Senior Managing Executive Officer, Chief Director of Sales, Head of Japan Business Unit, Director

Toru Kimura

59 2019 Managing Executive Officer, Senior Research Director, Director

Nobuhiko Tamura

63 2019 Managing Executive Officer, Chief Director of Reliability Assurance, Deputy Head of Japan Business Unit, Director